Invalid Symbol

Stock Research for INSY

INSY
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

INSY Stock Chart & Research Data

The INSY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the INSY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


INSY Due diligence Resources & Stock Charts

The INSY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View INSY Detailed Price Forecast - CNN Money CNN View INSY Detailed Summary - Google Finance
Yahoo View INSY Detailed Summary - Yahoo! Finance Zacks View INSY Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View INSY Trends & Analysis - Trade-Ideas Barrons View INSY Major Holders - Barrons
NASDAQ View INSY Call Transcripts - NASDAQ Seeking View INSY Breaking News & Analysis - Seeking Alpha
Spotlight View INSY Annual Report - CompanySpotlight.com OTC Report View INSY OTC Short Report - OTCShortReport.com
TradeKing View INSY Fundamentals - TradeKing Charts View INSY SEC Filings - Bar Chart
WSJ View Historical Prices for INSY - The WSJ Morningstar View Performance/Total Return for INSY - Morningstar
MarketWatch View the Analyst Estimates for INSY - MarketWatch CNBC View the Earnings History for INSY - CNBC
StockMarketWatch View the INSY Earnings - StockMarketWatch MacroAxis View INSY Buy or Sell Recommendations - MacroAxis
Bullish View the INSY Bullish Patterns - American Bulls Short Pains View INSY Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View INSY Stock Mentions - StockTwits PennyStocks View INSY Stock Mentions - PennyStockTweets
Twitter View INSY Stock Mentions - Twitter Invest Hub View INSY Investment Forum News - Investor Hub
Yahoo View INSY Stock Mentions - Yahoo! Message Board Seeking Alpha View INSY Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for INSY - SECform4.com Insider Cow View Insider Transactions for INSY - Insider Cow
CNBC View INSY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for INSY - OTC Markets
Yahoo View Insider Transactions for INSY - Yahoo! Finance NASDAQ View Institutional Holdings for INSY - NASDAQ


Stock Charts

FinViz View INSY Stock Insight & Charts - FinViz.com StockCharts View INSY Investment Charts - StockCharts.com
BarChart View INSY Stock Overview & Charts - BarChart Trading View View INSY User Generated Charts - Trading View


Latest Financial News for INSY

Opioid Litigants Get Boost From Senate Report
Posted on Tuesday February 13, 2018

A report released by Missouri Sen. Claire McCaskill points to $10 million of payments flowing from a group of five opioid-producing companies to 15 patient advocacy groups over a five-year period.


Opioid makers paid millions to advocacy groups -U.S. Senate report
Posted on Monday February 12, 2018

Five opioid manufacturers including OxyContin maker Purdue Pharma LP have paid more than $10 million to advocacy groups and doctors tied to them, many of whom amplified industry messages supporting the use of the painkillers, a U.S. Senate report said on Monday. The report, released by Democratic Senator Claire McCaskill, said groups who received the donations aligned themselves with industry goals and may have played a role in an epidemic that in 2016 led to 42,000 opioid overdose deaths. The report released by McCaskill, the U.S. Senate Homeland Security and Governmental Affairs Committee's ranking Democrat, said the groups issued guidance promoting opioids for chronic pain and lobbied against laws to curb their use.


Stocks give up early gains, Trump signs budget bill
Posted on Friday February 09, 2018

Yahoo Finance's LIVE market coverage and analysis of stocks and bonds begins each day at 11:45 a.m. ET.


INSYS Therapeutics Addresses Maryland Attorney General’s Motion
Posted on Friday February 09, 2018

PHOENIX, Feb. 09, 2018-- INSYS Therapeutics, Inc., a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released the following statement ...


Progenics Pharmaceuticals (PGNX) versus Insys Therapeutics (INSY) Head-To-Head ...
Dispatch Tribunal - Feb 18, 2018
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products.
Set Sail With FirstEnergy Corp. (FE), INSYS Therapeutics, Inc. (INSY) - StockNewsGazette
Is Insys Therapeutics Incorporated (NASDAQ:INSY)'s Fuel Running High? Reports ... - BZ Weekly

INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors
GlobeNewswire (press release) - Feb 1, 2018
“Vaseem brings a breadth and depth of global business experience to the INSYS board that we believe will strengthen the company's financial acumen,” said Steven Meyer, chairman of the INSYS Therapeutics board of directors. “We look forward to yet ...

INSYS Therapeutics Addresses New York Attorney General's Complaint
GlobeNewswire (press release) - Feb 2, 2018
INSYS Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients' quality of life.
New York Attorney General Sues INSYS Therapeutics For Deceptive, Illegal Practices - Green Market Report
AG Schneiderman Sues Fentanyl Maker Insys Therapeutics, Inc. For Dangerous And ... - LongIsland.com

INSYS Therapeutics Adds Two New Executives to Senior Management Team
GlobeNewswire (press release) - Jan 30, 2018
INSYS Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients' quality of life.
These two are the must watch stock's for the fearless investors: CoreCivic ... - StockNewsJournal
INSYS Therapeutics, Inc. (INSY) – Short Term Technical look - Stocks Gallery

Enter a stock symbol to view the stock details.